PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses (vol 476, pg 170, 2020)

Tian, H; Kang, YL; Song, XD; Xu, Y; Chen, HM; Gong, XQ; Zhang, WL; Xu, YY; Xia, XF; Gao, XD; Yao, WB

Gao, XD; Yao, WB (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Jiangsu Key Lab Druggabil Biopharmaceut, Nanjing 210009, Peoples R China.

CANCER LETTERS, 2021; 499 ():